Nylim GBL Ety R&D LDR ETF-UiWRNDETF

13F holders, Q2 2025 (June 30)
3holders
1new positions
1sold out
$32.43avg. 13F price*

At the end of Q2 2025, 3 institutions reported holding Nylim GBL Ety R&D LDR ETF-Ui (WRND) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were New York Life Investment Management LLC ($6.2M), GTS Securities LLC ($504K) and UBS Group AG ($5K).

Company
Nylim GBL Ety R&D LDR ETF-Ui
Filed as
NEW YORK LIFE INVESTMENTS ET (Q2 2025)
CUSIP
45409B255
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 4Q1 2024Q2 2024: 4Q2 2024Q3 2024: 4Q3 2024Q4 2024: 4Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 1Q4 2025Q1 2026: 4Q1 2026Q2 2026: 5Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions1$504K
Exits1$533K

All 13F filers, Q1 2025 → Q2 2025: 15,528 shares bought and 18,059 shares sold, net −2,531 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

New York Life Investment Management LLC 0.06% No change 190,000 $6.2M
GTS Securities LLC 0.02% New 15,528 $504K
UBS Group AG 0.00% No change 160 $5K

"% of holder's portfolio" is WRND's weight in each manager's 13F, not the share of Nylim GBL Ety R&D LDR ETF-Ui the manager owns.